{
  "abstract": "Telehealth for medication abortion has decreased many barriers to abortion care in the United States, but rhesus D (RhD) blood typing recommendations for patients beyond 84 days gestational duration can serve as a barrier for timely abortion.1–3 Additionally, self-determining RhD status may aid patients pursuing self-managed abortion, and can also reduce costs associated with travel, laboratory tests or time off work associated with traditional care at 84+ gestational days. EldonCard is a point-of-care RhD typing test.4",
  "authors": [
    {
      "affiliations": [
        "Department of Obstetrics, Gynecology and Women's Health, University of Hawai’i at Mānoa John A Burns School of Medicine, Honolulu, Hawaii, USA"
      ],
      "name": "Riana M Kawasaki"
    },
    {
      "affiliations": [
        "Department of Obstetrics, Gynecology and Women's Health, University of Hawai’i at Mānoa John A Burns School of Medicine, Honolulu, Hawaii, USA"
      ],
      "name": "Divya Dethier"
    },
    {
      "affiliations": [
        "Department of Obstetrics, Gynecology and Women's Health, University of Hawai’i at Mānoa John A Burns School of Medicine, Honolulu, Hawaii, USA"
      ],
      "name": "Reni Soon"
    },
    {
      "affiliations": [
        "Department of Obstetrics, Gynecology and Women's Health, University of Hawai’i at Mānoa John A Burns School of Medicine, Honolulu, Hawaii, USA"
      ],
      "name": "Lauren Sternberg"
    },
    {
      "affiliations": [
        "Department of Obstetrics, Gynecology and Women's Health, University of Hawai’i at Mānoa John A Burns School of Medicine, Honolulu, Hawaii, USA"
      ],
      "name": "Mary Tschann"
    }
  ],
  "title": "Patient accuracy and confidence in self-RhD typing using a point-of-care blood typing kit",
  "uid": "e1838f0f-5224-5fda-96e2-f7f6af73abf4"
}